The Current Status and Challenges in the Development of Vaccines and Drugs against Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2)

Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection causes coronavirus disease-19 (COVID-19), which is characterized by clinical manifestations such as pneumonia, lymphopenia, severe acute respiratory distress, and cytokine storm. S glycoprotein of SARS-CoV-2 binds to angiotensin-...

Descripción completa

Detalles Bibliográficos
Autores principales: Beeraka, Narasimha M., Tulimilli, SubbaRao V., Karnik, Medha, Sadhu, Surya P., Pragada, Rajeswara Rao, Aliev, Gjumrakch, Madhunapantula, SubbaRao V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168478/
https://www.ncbi.nlm.nih.gov/pubmed/34159203
http://dx.doi.org/10.1155/2021/8160860

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168478/
https://www.ncbi.nlm.nih.gov/pubmed/34159203
http://dx.doi.org/10.1155/2021/8160860

Ejemplares similares